首页> 外文期刊>Journal of the Bangladesh academy of sciences >In Vitro Antimicrobial Sensitivity of Escherichia coli Isolated from Clinical Sources
【24h】

In Vitro Antimicrobial Sensitivity of Escherichia coli Isolated from Clinical Sources

机译:从临床来源分离的大肠埃希菌的体外抗菌敏感性

获取原文
           

摘要

A study of antimicrobial sensitivity of Escherichia coli (E. coli) isolated from clinical sourcesof different diagnostic centers of Dhaka, Bangladesh was carried out to facilitate the choice of drugin the management of E. coli induced symptoms. Very low sensitivity of E. coli towards ampicillin(4%), aztreonam (4%), cloxacillin (5%), nalidixic acid (5%), ciprofloxacin (7.5%), ceftriaxone(12.5%), doxycycline (12.5%), ceftazidime (16.25%), co-trimoxazole (20%), chloramphenicol(22.51%), tetracycline (25%), and netilmicin (35%) was observed. Higher sensitivity pattern wasobserved for gentamicin (56%) and only imipenem (95%) showed sensitivity pattern possiblysusceptible enough to consider for the management of E. coli induced cases in the area under study.The low sensitivity to different antimicrobial could be attributed to their prevailing usage and abusein the area under study.
机译:从孟加拉国达卡市不同诊断中心的临床来源分离出的大肠杆菌(E. coli)的抗菌敏感性进行了研究,以促进在治疗大肠杆菌引起的症状中选择药物。大肠杆菌对氨苄西林(4%),氨曲南(4%),氯沙西林(5%),萘啶酸(5%),环丙沙星(7.5%),头孢曲松(12.5%),多西环素(12.5%)的敏感性极低观察到头孢他啶(16.25%),三甲唑(20%),氯霉素(22.51%),四环素(25%)和奈替米星(35%)。庆大霉素(56%)的敏感性模式较高,只有亚胺培南(95%)的敏感性模式可能足以考虑用于研究区域内大肠杆菌诱导的病例的管理。研究区域中的普遍用法和滥用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号